{"id":"cathflo-activase-alteplase","safety":{"commonSideEffects":[{"rate":null,"effect":"Bleeding"},{"rate":null,"effect":"Sepsis"},{"rate":null,"effect":"Catheter-related infection"}]},"_chembl":{"chemblId":"CHEMBL1201593","moleculeType":"Enzyme"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Alteplase is a recombinant human tissue plasminogen activator that directly activates the fibrinolytic system by converting plasminogen to plasmin. Plasmin then degrades fibrin, the structural protein in blood clots, leading to clot dissolution. Cathflo Activase is specifically formulated for catheter-directed thrombolysis to restore patency of occluded central venous catheters.","oneSentence":"Alteplase is a tissue plasminogen activator (tPA) that converts plasminogen to plasmin, which breaks down fibrin clots.","_ai_confidence":"high"},"_scrapedAt":"2026-03-27T23:43:09.437Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Restoration of function to central venous catheters occluded by thrombus"}]},"trialDetails":[{"nctId":"NCT06184321","phase":"EARLY_PHASE1","title":"Alteplase Through an Indwelling Pleural Catheter for the Management of Symptomatic Septated Malignant Pleural Effusion","status":"RECRUITING","sponsor":"M.D. Anderson Cancer Center","startDate":"2023-08-17","conditions":"Hematopoietic and Lymphoid Cell Neoplasm, Malignant Solid Neoplasm","enrollment":30},{"nctId":"NCT02315898","phase":"PHASE2","title":"Inhaled Tissue Plasminogen Activator for Acute Plastic Bronchitis","status":"COMPLETED","sponsor":"University of Michigan","startDate":"2018-03-19","conditions":"Plastic Bronchitis, Protein-Losing Enteropathies, Healthy","enrollment":40},{"nctId":"NCT04806373","phase":"PHASE4","title":"Intrapleural Fibrinolytic Therapy to Enhance Chemical Pleurodesis Enhance Chemical Pleurodesis","status":"COMPLETED","sponsor":"Memorial Healthcare System","startDate":"2021-06-15","conditions":"Pleural Effusion","enrollment":27},{"nctId":"NCT05429476","phase":"PHASE3","title":"EXtending the Time Window for Thrombolysis in Posterior Circulation Stroke Without Early CT Signs","status":"COMPLETED","sponsor":"Second Affiliated Hospital, School of Medicine, Zhejiang University","startDate":"2022-08-17","conditions":"Stroke, Acute Ischemic","enrollment":234},{"nctId":"NCT03581877","phase":"PHASE4","title":"Peripheral Systemic Thrombolysis Versus Catheter Directed Thrombolysis for Submassive PE","status":"ACTIVE_NOT_RECRUITING","sponsor":"Northwell Health","startDate":"2019-01-28","conditions":"Pulmonary Embolism, Pulmonary Hypertension, Thromboembolism","enrollment":31},{"nctId":"NCT02474810","phase":"NA","title":"Intensive Versus Standard Hemodialysis CVC Dysfunction Protocol","status":"COMPLETED","sponsor":"Nova Scotia Health Authority","startDate":"2013-01","conditions":"Chronic Renal Insufficiency","enrollment":35},{"nctId":"NCT05540834","phase":"PHASE2","title":"Viscoelastic Testing Guided Tissue Plasminogen Activator Treatment in Acute Respiratory Failure","status":"RECRUITING","sponsor":"South West Sydney Local Health District","startDate":"2022-05-18","conditions":"Acute Respiratory Failure, Hypercoagulability, Fibrinolysis Shutdown","enrollment":70},{"nctId":"NCT05258565","phase":"PHASE1","title":"TPA in Acute Stroke With COVID Verus Non-COVID-19 Patients","status":"COMPLETED","sponsor":"Assiut University","startDate":"2022-03-01","conditions":"Acute Ischemic Stroke","enrollment":50},{"nctId":"NCT04357730","phase":"PHASE2","title":"Fibrinolytic Therapy to Treat ARDS in the Setting of COVID-19 Infection","status":"COMPLETED","sponsor":"Denver Health and Hospital Authority","startDate":"2020-05-14","conditions":"Severe Acute Respiratory Syndrome, Respiratory Failure, Acute Respiratory Distress Syndrome","enrollment":50},{"nctId":"NCT01513759","phase":"PHASE3","title":"Submassive and Massive Pulmonary Embolism Treatment With Ultrasound Accelerated Thrombolysis Therapy","status":"COMPLETED","sponsor":"Boston Scientific Corporation","startDate":"2012-06-07","conditions":"Pulmonary Embolism, Acute Pulmonary Embolism, Sub-massive Pulmonary Embolism","enrollment":150},{"nctId":"NCT03988842","phase":"PHASE4","title":"Standard-dose Apixaban AFtEr Very Low-dose ThromboLYSis for Acute Intermediate-high Risk Acute Pulmonary Embolism","status":"TERMINATED","sponsor":"Victor Tapson, MD","startDate":"2019-07-25","conditions":"Pulmonary Embolism With Acute Cor Pulmonale, Pulmonary Embolism, Pulmonary Embolism With Pulmonary Infarction","enrollment":4},{"nctId":"NCT01717742","phase":"PHASE3","title":"Intrapleural DNase and Tissue Plasminogen Activator in Pediatric Empyema (DTPA Trial)","status":"COMPLETED","sponsor":"The Hospital for Sick Children","startDate":"2012-12","conditions":"Pleural Empyema","enrollment":97},{"nctId":"NCT01827046","phase":"PHASE3","title":"Minimally Invasive Surgery Plus Rt-PA for ICH Evacuation Phase III","status":"COMPLETED","sponsor":"Johns Hopkins University","startDate":"2013-12-30","conditions":"Intracerebral Hemorrhage","enrollment":499},{"nctId":"NCT01576679","phase":"PHASE3","title":"Safety and Efficacy of the Use of Tissue Plasminogen Activator (tPA) in Intra-Abdominal Collections in Children - A Prospective Study","status":"TERMINATED","sponsor":"The Hospital for Sick Children","startDate":"2012-03","conditions":"Intra-abdominal Abscess","enrollment":28},{"nctId":"NCT02002325","phase":"PHASE3","title":"THrombolysis for Acute Wake-up and Unclear-onset Strokes With Alteplase at 0.6 mg/kg Trial (THAWS)","status":"UNKNOWN","sponsor":"National Cerebral and Cardiovascular Center, Japan","startDate":"2014-05","conditions":"Stroke","enrollment":300},{"nctId":"NCT00784134","phase":"PHASE3","title":"Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage Phase III","status":"COMPLETED","sponsor":"Johns Hopkins University","startDate":"2009-07","conditions":"Intraventricular Hemorrhage","enrollment":500},{"nctId":"NCT01525290","phase":"PHASE3","title":"Efficacy and Safety of MRI-based Thrombolysis in Wake-up Stroke","status":"COMPLETED","sponsor":"Universitätsklinikum Hamburg-Eppendorf","startDate":"2012-09","conditions":"Stroke","enrollment":501},{"nctId":"NCT01580839","phase":"PHASE3","title":"EXTEND (International): Extending the Time for Thrombolysis in Emergency Neurological Deficits (International)","status":"COMPLETED","sponsor":"Neuroscience Trials Australia","startDate":"2012-12-06","conditions":"Stroke","enrollment":45},{"nctId":"NCT00887328","phase":"PHASE3","title":"Extending the Time for Thrombolysis in Emergency Neurological Deficits","status":"COMPLETED","sponsor":"Neuroscience Trials Australia","startDate":"2010-06","conditions":"Stroke","enrollment":180},{"nctId":"NCT02767232","phase":"PHASE3","title":"Pediatric High-Risk Deep Venous Thrombosis Lytic Outcomes Trial","status":"WITHDRAWN","sponsor":"University of Colorado, Denver","startDate":"2018-07","conditions":"Deep Vein Thrombosis, Post-Thrombotic Syndrome, Venous Thrombosis","enrollment":""},{"nctId":"NCT02072226","phase":"PHASE3","title":"A Study of the Efficacy and Safety of Alteplase in Participants With Mild Stroke","status":"TERMINATED","sponsor":"Genentech, Inc.","startDate":"2014-05-31","conditions":"Stroke","enrollment":313},{"nctId":"NCT01591096","phase":"PHASE1","title":"Thrombolysis in Pediatric Stroke (TIPS)","status":"TERMINATED","sponsor":"Seattle Children's Hospital","startDate":"2012-10","conditions":"Stroke","enrollment":1},{"nctId":"NCT00265005","phase":"PHASE1","title":"Safety and Efficacy of Tissue Plasminogen Activator (tPA) in Neonates and Infants","status":"TERMINATED","sponsor":"University of Louisville","startDate":"2005-06","conditions":"Thrombosis","enrollment":12},{"nctId":"NCT00790335","phase":"PHASE3","title":"Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis","status":"COMPLETED","sponsor":"Washington University School of Medicine","startDate":"2009-11","conditions":"Deep Vein Thrombosis, Venous Thrombosis, Postphlebitic Syndrome","enrollment":692},{"nctId":"NCT00650858","phase":"PHASE2","title":"Clinical Trial on Treatment of Intraventricular Hemorrhage","status":"COMPLETED","sponsor":"Johns Hopkins University","startDate":"2004-02","conditions":"Intraventricular Hemorrhage","enrollment":52},{"nctId":"NCT01282242","phase":"PHASE2","title":"A Study of Intravenous Thrombolysis With Alteplase in MRI-Selected Patients","status":"COMPLETED","sponsor":"Lee Schwamm","startDate":"2011-01","conditions":"Acute Stroke","enrollment":88},{"nctId":"NCT01643902","phase":"PHASE2","title":"Safety of Intravenous Thrombolytics in Stroke on Awakening","status":"COMPLETED","sponsor":"Johns Hopkins University","startDate":"2013-01","conditions":"Stroke","enrollment":20},{"nctId":"NCT01870492","phase":"","title":"Improving Patient Access to Stroke Therapy Study","status":"TERMINATED","sponsor":"Medical College of Wisconsin","startDate":"2014-01","conditions":"Ischemic Stroke, Transient Ischemic Attack","enrollment":500},{"nctId":"NCT01977456","phase":"PHASE2","title":"Study of the Combination Therapy of Rt-PA and Eptifibatide to Treat Acute Ischemic Stroke (CLEAR-FDR)","status":"COMPLETED","sponsor":"Arthur Pancioli","startDate":"2013-09","conditions":"Stroke, Brain Infarction","enrollment":27},{"nctId":"NCT01878136","phase":"PHASE1, PHASE2","title":"Effect of Intraventricular tPA Following Aneurysmal Subarachnoid Hemorrhage","status":"WITHDRAWN","sponsor":"Rush University Medical Center","startDate":"2015-03","conditions":"Subarachnoid Hemorrhage, Cerebral Vasospasm, Cerebral Aneurysm","enrollment":""},{"nctId":"NCT02180204","phase":"PHASE2, PHASE3","title":"Tenecteplase Versus Alteplase in Ischemic Stroke Management (TALISMAN)","status":"WITHDRAWN","sponsor":"Reza Behrouz, DO","startDate":"2015-01","conditions":"Ischemic Stroke","enrollment":""},{"nctId":"NCT00224770","phase":"PHASE2","title":"Minimally Invasive Surgery and rtPA for Intracerebral Hemorrhage Evacuation","status":"COMPLETED","sponsor":"Daniel Hanley","startDate":"2005-08","conditions":"Intracerebral Hemorrhage","enrollment":141},{"nctId":"NCT02472574","phase":"PHASE2","title":"Dose-effect Relationship of Rt-PA on ICH Evacuation","status":"UNKNOWN","sponsor":"Tongji Hospital","startDate":"2015-06","conditions":"Hypertensive Intracerebral Hemorrhage","enrollment":108},{"nctId":"NCT00284739","phase":"PHASE2","title":"Alteplase for Percutaneous Treatment of Loculated Abdominopelvic Abscesses","status":"COMPLETED","sponsor":"Kaiser Permanente","startDate":"2006-02","conditions":"Abdominal Abscess, Pelvic Abscess","enrollment":20},{"nctId":"NCT01183533","phase":"PHASE2","title":"Safety of Intravenous Thrombolysis for Wake-up Stroke","status":"COMPLETED","sponsor":"The University of Texas Health Science Center, Houston","startDate":"2010-07","conditions":"Ischemic Stroke","enrollment":40},{"nctId":"NCT00082355","phase":"PHASE2","title":"Low-Dose Alteplase to Treat Blood Clots in Deep Leg Veins","status":"COMPLETED","sponsor":"Richard Chang, M.D.","startDate":"2004-05","conditions":"Acute Deep Venous Thrombosis of the Lower Extremity","enrollment":30},{"nctId":"NCT00894803","phase":"PHASE2","title":"Study of the Combination Therapy of Rt-PA and Eptifibatide to Treat Acute Ischemic Stroke","status":"COMPLETED","sponsor":"University of Cincinnati","startDate":"2009-07","conditions":"Ischemic Stroke, Stroke, Brain Infarction","enrollment":126},{"nctId":"NCT00307580","phase":"PHASE4","title":"Cathflo Activase Pediatric Study","status":"COMPLETED","sponsor":"Genentech, Inc.","startDate":"2002-04","conditions":"Dysfunctional Central Venous Access Devices (CVADS)","enrollment":300},{"nctId":"NCT00359424","phase":"PHASE3","title":"Interventional Management of Stroke (IMS) III Trial","status":"TERMINATED","sponsor":"Joseph Broderick","startDate":"2006-08","conditions":"Stroke","enrollment":656},{"nctId":"NCT01150266","phase":"PHASE1","title":"Study for the Use of Alteplase in Patients Who Awaken With Stroke","status":"WITHDRAWN","sponsor":"University of California, San Diego","startDate":"2011-08","conditions":"Ischemic Stroke","enrollment":""},{"nctId":"NCT01670474","phase":"PHASE4","title":"Prolonged Hemodialysis Catheter Survival With Copolymer Coating and Rt-PA","status":"UNKNOWN","sponsor":"Centre Hospitalier du Centre du Valais","startDate":"2011-01","conditions":"Malfunction; Catheter, Thrombosis, Mechanical Complication of Hemodialysis Catheter","enrollment":240},{"nctId":"NCT00468104","phase":"NA","title":"Efficacy and Safety of Activase (Ateplase) vs Placebo in Complicated Pleural Effusions (CPE)/Empyemas","status":"COMPLETED","sponsor":"Midwest Pulmonary and Critical Care","startDate":"2004-04","conditions":"Pleural Effusion Associated With Pulmonary Infection, Bacterial Pleural Effusion Other Than Tuberculosis","enrollment":100},{"nctId":"NCT01455935","phase":"PHASE2","title":"Wake up Symptomatic Stroke - Benefit of Intravenous Clot Busters or Endovascular Intervention","status":"UNKNOWN","sponsor":"Jacobs Neurological Institute","startDate":"2011-11","conditions":"Stroke","enrollment":90},{"nctId":"NCT00624000","phase":"NA","title":"IV vs. IA tPA (Activase) in Acute Ischemic Stroke With CTA Evidence of Major Vessel Occlusion","status":"COMPLETED","sponsor":"University of North Carolina, Chapel Hill","startDate":"2004-03","conditions":"Ischemic Stroke","enrollment":7},{"nctId":"NCT01098890","phase":"PHASE2","title":"Intraventricular Tissue Plasminogen Activator (tPA) in the Management of Aneurysmal Subarachnoid Hemorrhage","status":"UNKNOWN","sponsor":"University of Calgary","startDate":"2009-10","conditions":"Aneurysmal Subarachnoid Hemorrhage, Intraventricular Hemorrhage","enrollment":12},{"nctId":"NCT00250991","phase":"PHASE1, PHASE2","title":"Combined Approach to Lysis Utilizing Eptifibatide and rt-PA in Acute Ischemic Stroke (CLEAR Stroke) Trial","status":"COMPLETED","sponsor":"University of Cincinnati","startDate":"2003-07","conditions":"Stroke","enrollment":94},{"nctId":"NCT00303420","phase":"PHASE4","title":"Alteplase for Blood Flow Restoration in Hemodialysis Catheters","status":"TERMINATED","sponsor":"University of Manitoba","startDate":"2004-09","conditions":"Thrombosis","enrollment":180}],"_emaApprovals":[],"_faersSignals":[{"count":2,"reaction":"HYPOTENSION"},{"count":1,"reaction":"ASTHENIA"},{"count":1,"reaction":"CONVULSION"},{"count":1,"reaction":"COUGH"},{"count":1,"reaction":"DIPLOPIA"},{"count":1,"reaction":"DIZZINESS"},{"count":1,"reaction":"DRUG HYPERSENSITIVITY"},{"count":1,"reaction":"DYSPNOEA"},{"count":1,"reaction":"FATIGUE"},{"count":1,"reaction":"FEELING COLD"}],"_approvalHistory":[],"publicationCount":9,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"Cathflo Activase (Alteplase)","genericName":"Cathflo Activase (Alteplase)","companyName":"Genentech, Inc.","companyId":"genentech-inc","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Alteplase is a tissue plasminogen activator (tPA) that converts plasminogen to plasmin, which breaks down fibrin clots. Used for Restoration of function to central venous catheters occluded by thrombus.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}